image
Healthcare - Biotechnology - NASDAQ - US
$ 64.63
-2.64 %
$ 4.11 B
Market Cap
-14.45
P/E
INCOME STATEMENT
130 M REVENUE
68.06%
-266 M OPERATING INCOME
-44.02%
-261 M NET INCOME
-41.11%
EFFICIENCY
Earnings Waterfall Rhythm Pharmaceuticals, Inc.
image
Revenue 130 M
Cost Of Revenue 13.4 M
Gross Profit 117 M
Operating Expenses 382 M
Operating Income -266 M
Other Expenses -4.9 M
Net Income -261 M
150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)(300m)(300m)130m(13m)117m(382m)(266m)5m(261m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 130.1 77.4 23.6 3.2 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 13.4 9.3 2.1 0.6 0.7 0.8 0.4 0.2 0.1 0 0 0 0
Gross Profit 116.8 68.1 21.5 2.6 (0.7) (0.8) (0.4) (0.2) (0.1) 0 0 0 0
OPERATING INCOME
Operating Expenses 382.3 252.5 200.7 172.6 136.6 146.0 78.4 32.4 25.9 10.6 6.5 21.4 18.1
Selling, General and Administrative Expenses 144.3 117.5 92.0 68.5 46.1 36.5 28.1 9.5 6.3 3.4 1.2 3.4 2.5
Research and Development Expenses 238.0 135.0 108.6 104.1 90.5 109.5 50.3 22.9 19.6 7.1 5.3 18.0 15.7
Operating Income (265.5) (184.4) (179.2) (170.1) (136.6) (146.0) (78.4) (32.4) (25.9) (10.6) (6.5) (21.4) (18.1)
PRE-TAX INCOME
Interest Income Expense 20.6 13.9 5.2 0 0 0 0 0 0 0 0 0 0
Total Other Income 5.2 0.2 (2.0) 100.4 2.6 5.3 4.4 (1.3) 33 K (0.5) 0 17 K 8 K
Pre-Tax Income (260.3) (184.1) (181.1) (69.6) (134.0) (140.7) (74.1) (33.7) (25.9) (11.1) (6.5) (21.4) (18.1)
NET INCOME
Tax Provision 0.3 0.6 2.0 (1.6) (3.3) (6.1) 4.4 1.1 0 0 0 0 0
Net Income (260.6) (184.7) (183.1) (68.0) (130.7) (134.6) (74.1) (33.7) (25.9) (11.1) (6.5) (21.4) (18.1)
EPS 4.21 3.2 3.51 1.37 2.96 3.7 2.39 2.54 1.55 0.66 0.64 0.43 0.36